Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.83
-0.24 (-0.80%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
3 No-Brainer Stocks to Buy for Under $100 Right Now
June 22, 2024
You won't need much money to start investing in these great stocks.
Via
The Motley Fool
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
June 22, 2024
The pharmaceutical industry giants offer reliable profit growth and above-average dividend yields.
Via
The Motley Fool
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
June 21, 2024
The FDA has approved Sarepta Therapeutics' Elevidys for treating Duchenne muscular dystrophy in patients aged 4 and older with specific DMD gene mutations.
Via
Benzinga
Exposures
Product Safety
How Is The Market Feeling About Pfizer?
June 14, 2024
Via
Benzinga
Is It Too Late to Buy Pfizer Stock?
June 14, 2024
It's no secret that the last year has been punishing.
Via
The Motley Fool
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
June 20, 2024
The agency signed off on Elevidys for a broad population of children with the muscle-wasting disease.
Via
Investor's Business Daily
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threatens the state's business-friendly reputation and judicial consistency.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns
June 20, 2024
These are the undervalued blue-chip stocks to buy, as they represent companies with strong fundamentals and robust cash flow outlooks.
Via
InvestorPlace
Supreme Court Upholds 2017 Tax On Foreign Profits For US Businesses
June 20, 2024
US Supreme Court upholds 2017 tax on foreign business income, citing Congress' constitutional power to tax. Justices Kavanaugh, Thomas, and Gorsuch dissented.
Via
Benzinga
3 Underrated Dividend Stock Machines to Turbocharge Your Income
June 20, 2024
If you are a passive income investor, take a look at these underrated dividend stocks to buy for steady income.
Via
InvestorPlace
7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027
June 20, 2024
Discover these blue-chip stocks to buy in the biotechnology, banking, pharmaceuticals, tobacco, restaurants, and entertainment industries.
Via
InvestorPlace
Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis
June 19, 2024
CEOs of Palantir, Oracle, and Pfizer lobbied US senators for support of Israel during Gaza invasion and discussed solutions for hostages held by Hamas.
Via
Benzinga
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
June 18, 2024
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...
Via
Benzinga
Exposures
COVID-19
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
June 18, 2024
These two pharma stocks are beloved by income investors.
Via
The Motley Fool
FDA Approves Merck's Pneumococcal Vaccine As First Shot Designed For Adults
June 18, 2024
The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced...
Via
Benzinga
Exposures
Product Safety
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?
June 17, 2024
BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.
Via
Benzinga
Exposures
Product Safety
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims
June 17, 2024
Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and...
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
June 15, 2024
Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
June 14, 2024
The company just unveiled preclinical results from a test of its GLP-1 weight-loss drug.
Via
Investor's Business Daily
3 Stocks to Sell as Ozempic Surges in Popularity
June 14, 2024
GLP-1s are a weight-loss breakthrough, but these three stocks to sell have a lot to lose from their rapid rise in popularity.
Via
InvestorPlace
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
June 13, 2024
Sarepta is now just awaiting the FDA's decision on whether to fully approve its gene therapy, and for whom.
Via
Investor's Business Daily
Exposures
Product Safety
What's Going On With Pfizer On Thursday? Pharma Giant's Shares Tick Lower
June 13, 2024
Pfizer Inc. reported that its Phase 3 CIFFREO study on Duchenne muscular dystrophy (DMD) gene therapy did not meet its primary effectiveness goal. Despite efforts to improve motor functions in boys...
Via
Benzinga
Exposures
COVID-19
3 Ultra-High-Yield Dividend Stocks Billionaires Are Sinking Their Teeth Into
June 13, 2024
Prominent billionaire money managers are piling into three industry-leading businesses with supercharged yields ranging from 6% to 15.1%!
Via
The Motley Fool
3 Hidden-Gem Value Stocks to Buy and Never Let Go
June 12, 2024
Here are three top hidden-gem value stocks long-term investors would do well to consider on any meaningful dips moving forward.
Via
InvestorPlace
7 Recession-Proof Stocks to Buy Now for Peace of Mind
June 11, 2024
Dive into the fundamentals behind the resilience of recession-proof stocks and the performance indicators driving their success.
Via
InvestorPlace
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
June 11, 2024
These penny stocks to buy provide a good opportunity for investors to buy low-priced stocks that provide significant growth potential.
Via
InvestorPlace
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
June 11, 2024
After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.
Via
InvestorPlace
Exposures
Product Safety
Billionaires Are Buying These 2 Ultra-High-Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?
June 11, 2024
These high-yield dividend payers have what it takes to pump up your portfolio's passive income stream.
Via
The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
June 11, 2024
These pharma and biotech players could become long-term winners.
Via
The Motley Fool
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.